Intra-Cellular Therapies, Inc.
Intra-Cellular Therapies Prices $114 Million Public Offering of Common Stock
NEW YORK, March 5, 2015 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company, today announced the pricing of its previously announced underwritten public offering of 4,750,000 shares of its common stock at a public offering price of $24.00 per share. All of the shares in the offering will be sold by Intra-Cellular Therapies. Net proceeds to Intra-Cellular Therapies from the sale of the shares, after deducting underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $106.5 million.
Tekmira Conference Call and Webcast Advisory: Corporate Update and Full Year 2014 Financial Results
VANCOUVER, British Columbia, March 5, 2015 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR), a biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection (HBV), announced that it will hold a conference call and webcast on Thursday, March 12, 2015 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to provide a corporate update and report on its financial results for the fourth quarter and year ended December 31, 2014.
1st Century Bancshares, Inc.
1st Century Bancshares, Inc. Reports Financial Results for the Quarter and Year Ended December 31, 2014
LOS ANGELES, March 5, 2015 (GLOBE NEWSWIRE) -- 1st Century Bancshares, Inc. (the "Company") (Nasdaq:FCTY), the holding company for 1st Century Bank, N.A. (the "Bank"), today reported net income for the quarter and year ended December 31, 2014 of $554,000 and $2.4 million, respectively, compared to $217,000 and $6.9 million for the same periods last year. The net income variance during the year ended December 31, 2014, compared to the same period last year, was primarily attributable to a $5.0 million increase in income tax provisions. This increase was related to an income tax benefit of approximately $3.1 million recognized during the year ended December 31, 2013 in connection with the reversal of our deferred tax valuation allowance, as compared to $1.9 million of income tax provisions recognized during the year ended December 31, 2014. Pre-tax, pre-provision earnings for the quarter and year ended December 31, 2014 was $1.1 million and $4.4 million, respectively, compared to $736,000 and $3.9 million for the same periods last year. Included in net income for the quarter and year ended December 31, 2014 are gains in connection with the sale of securities of $196,000 and $1.2 million, respectively, compared to $117,000 and $822,000 for the same periods last year.
Mobile Pay Parking has arrived in Toronto
TORONTO, ON, March 5, 2015 (GLOBE NEWSWIRE) -- via PRWEB - The Toronto Parking Authority (TPA) today announced the roll out of the new Green P App. It replaces the existing Green P parking location app.
ABB publishes 2014 annual report
Zurich, Switzerland, March 5, 2015 – ABB Ltd has published its 2014 annual
report on its web site and has filed the annual report on Form 20-F with the
United States Securities and Exchange Commission.
The 2014 annual report is now available electronically at www.abb.com/news
(>Media resources>ABB Group reports), or at www.abb.com/investorrelations
(>Financial results and presentations>Quarterly results and annual reports).
Shareholders may request a hard copy of the report free of charge thro